Replies to post #222624 on $Pistol Pete$, $Mick$ & Friends Stock Picks /news,

[mick]

$MRNA TARGET $95
3 Moderna Analyst Takes On The Coronavirus Vaccine Developer's Pipeline
2020 Sep 18, 12:35pm | 4 min read
Coronavirus vaccine developer Moderna Inc (NASDAQ: MRNA) held a virtual R&D event Thursday, showcasing its portfolio and key therapeutic areas. The Moderna Analysts: Chardan analyst Geulah Livshits has a Buy rating on Moderna with a $95 price target. SVB Leerink analyst Mani...

[MONEYBAGSCLAY]

So do I SIRC getting a lot of eyes on it now ... solar industry growing